Cargando…

Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study

OBJECTIVE: In the setting of reperfused ST-elevation myocardial infarction (STEMI), increased production of reactive oxygen species (ROS) contributes to reperfusion injury. Among ROS, hydrogen peroxide (H(2)O(2)) showed toxic effects on human cardiomyocytes and may induce microcirculatory impairment...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanzilli, Gaetano, Truscelli, Giovanni, Arrivi, Alessio, Carnevale, Roberto, Placanica, Attilio, Viceconte, Nicola, Raparelli, Valeria, Mele, Rita, Cammisotto, Vittoria, Nocella, Cristina, Barillà, Francesco, Lucisano, Luigi, Pennacchi, Mauro, Granatelli, Antonino, Dominici, Marcello, Basili, Stefania, Gaudio, Carlo, Mangieri, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701599/
https://www.ncbi.nlm.nih.gov/pubmed/31399448
http://dx.doi.org/10.1136/bmjopen-2018-025884
_version_ 1783445077624881152
author Tanzilli, Gaetano
Truscelli, Giovanni
Arrivi, Alessio
Carnevale, Roberto
Placanica, Attilio
Viceconte, Nicola
Raparelli, Valeria
Mele, Rita
Cammisotto, Vittoria
Nocella, Cristina
Barillà, Francesco
Lucisano, Luigi
Pennacchi, Mauro
Granatelli, Antonino
Dominici, Marcello
Basili, Stefania
Gaudio, Carlo
Mangieri, Enrico
author_facet Tanzilli, Gaetano
Truscelli, Giovanni
Arrivi, Alessio
Carnevale, Roberto
Placanica, Attilio
Viceconte, Nicola
Raparelli, Valeria
Mele, Rita
Cammisotto, Vittoria
Nocella, Cristina
Barillà, Francesco
Lucisano, Luigi
Pennacchi, Mauro
Granatelli, Antonino
Dominici, Marcello
Basili, Stefania
Gaudio, Carlo
Mangieri, Enrico
author_sort Tanzilli, Gaetano
collection PubMed
description OBJECTIVE: In the setting of reperfused ST-elevation myocardial infarction (STEMI), increased production of reactive oxygen species (ROS) contributes to reperfusion injury. Among ROS, hydrogen peroxide (H(2)O(2)) showed toxic effects on human cardiomyocytes and may induce microcirculatory impairment. Glutathione (GSH) is a water-soluble tripeptide with a potent oxidant scavenging activity. We hypothesised that the infusion of GSH before acute reoxygenation might counteract the deleterious effects of increased H(2)O(2) generation on myocardium. METHODS: Fifty consecutive patients with STEMI, scheduled to undergo primary angioplasty, were randomly assigned, before intervention, to receive an infusion of GSH (2500 mg/25 mL over 10 min), followed by drug administration at the same doses at 24, 48 and 72 hours elapsing time or placebo. Peripheral blood samples were obtained before and at the end of the procedure, as well as after 5 days. H(2)O(2) production, 8-iso-prostaglandin F2α (PGF2α) formation, H(2)O(2) breakdown activity (HBA) and nitric oxide (NO) bioavailability were determined. Serum cardiactroponin T (cTpT) was measured at admission and up to 5 days. RESULTS: Following acute reperfusion, a significant reduction of H(2)O(2) production (p=0.0015) and 8-iso-PGF2α levels (p=0.0003), as well as a significant increase in HBA (p<0.0001)and NO bioavailability (p=0.035), was found in the GSH group as compared with placebo. In treated patients, attenuated production of H(2)O(2) persisted up to 5 days from the index procedure (p=0.009) and these changes was linked to those of the cTpT levels (r=0.41, p=0.023). CONCLUSION: The prophylactic and prolonged infusion of GSH seems to determine a rapid onset and persistent blunting of H(2)O(2) generation improving myocardial cell survival. Nevertheless, a larger trial, adequately powered for evaluation of clinical endpoints, is ongoing to confirm the current finding. TRIAL REGISTRATION NUMBER: EUDRACT 2014-00448625; Pre-results.
format Online
Article
Text
id pubmed-6701599
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67015992019-09-02 Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study Tanzilli, Gaetano Truscelli, Giovanni Arrivi, Alessio Carnevale, Roberto Placanica, Attilio Viceconte, Nicola Raparelli, Valeria Mele, Rita Cammisotto, Vittoria Nocella, Cristina Barillà, Francesco Lucisano, Luigi Pennacchi, Mauro Granatelli, Antonino Dominici, Marcello Basili, Stefania Gaudio, Carlo Mangieri, Enrico BMJ Open Cardiovascular Medicine OBJECTIVE: In the setting of reperfused ST-elevation myocardial infarction (STEMI), increased production of reactive oxygen species (ROS) contributes to reperfusion injury. Among ROS, hydrogen peroxide (H(2)O(2)) showed toxic effects on human cardiomyocytes and may induce microcirculatory impairment. Glutathione (GSH) is a water-soluble tripeptide with a potent oxidant scavenging activity. We hypothesised that the infusion of GSH before acute reoxygenation might counteract the deleterious effects of increased H(2)O(2) generation on myocardium. METHODS: Fifty consecutive patients with STEMI, scheduled to undergo primary angioplasty, were randomly assigned, before intervention, to receive an infusion of GSH (2500 mg/25 mL over 10 min), followed by drug administration at the same doses at 24, 48 and 72 hours elapsing time or placebo. Peripheral blood samples were obtained before and at the end of the procedure, as well as after 5 days. H(2)O(2) production, 8-iso-prostaglandin F2α (PGF2α) formation, H(2)O(2) breakdown activity (HBA) and nitric oxide (NO) bioavailability were determined. Serum cardiactroponin T (cTpT) was measured at admission and up to 5 days. RESULTS: Following acute reperfusion, a significant reduction of H(2)O(2) production (p=0.0015) and 8-iso-PGF2α levels (p=0.0003), as well as a significant increase in HBA (p<0.0001)and NO bioavailability (p=0.035), was found in the GSH group as compared with placebo. In treated patients, attenuated production of H(2)O(2) persisted up to 5 days from the index procedure (p=0.009) and these changes was linked to those of the cTpT levels (r=0.41, p=0.023). CONCLUSION: The prophylactic and prolonged infusion of GSH seems to determine a rapid onset and persistent blunting of H(2)O(2) generation improving myocardial cell survival. Nevertheless, a larger trial, adequately powered for evaluation of clinical endpoints, is ongoing to confirm the current finding. TRIAL REGISTRATION NUMBER: EUDRACT 2014-00448625; Pre-results. BMJ Publishing Group 2019-08-08 /pmc/articles/PMC6701599/ /pubmed/31399448 http://dx.doi.org/10.1136/bmjopen-2018-025884 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular Medicine
Tanzilli, Gaetano
Truscelli, Giovanni
Arrivi, Alessio
Carnevale, Roberto
Placanica, Attilio
Viceconte, Nicola
Raparelli, Valeria
Mele, Rita
Cammisotto, Vittoria
Nocella, Cristina
Barillà, Francesco
Lucisano, Luigi
Pennacchi, Mauro
Granatelli, Antonino
Dominici, Marcello
Basili, Stefania
Gaudio, Carlo
Mangieri, Enrico
Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
title Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
title_full Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
title_fullStr Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
title_full_unstemmed Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
title_short Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
title_sort glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701599/
https://www.ncbi.nlm.nih.gov/pubmed/31399448
http://dx.doi.org/10.1136/bmjopen-2018-025884
work_keys_str_mv AT tanzilligaetano glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT truscelligiovanni glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT arrivialessio glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT carnevaleroberto glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT placanicaattilio glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT vicecontenicola glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT raparellivaleria glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT melerita glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT cammisottovittoria glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT nocellacristina glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT barillafrancesco glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT lucisanoluigi glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT pennacchimauro glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT granatelliantonino glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT dominicimarcello glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT basilistefania glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT gaudiocarlo glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy
AT mangierienrico glutathioneinfusionbeforeprimarypercutaneouscoronaryinterventionarandomisedcontrolledpilotstudy